Search
Elanco Animal Health Inc
ELANAdd to Watchlist
26.370USD
-0.070-0.26%
Close 07-31 16:00（ET）Quotes delayed by 15 min
13.17BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Elanco Animal Health Inc is 8.75, ranking 7 out of 155 in the Pharmaceuticals industry. The average price target is 25.00, with a high of 30.00 and a low of 18.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
30.144
Target Price
+14.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
54
Total
5
Median
7
Average
Company name
Ratings
Analysts
Elanco Animal Health Inc
ELAN
17
Apple Inc
AAPL
48
Ge Vernova Inc
GEV
37
Tapestry Inc
TPR
24
Verisk Analytics Inc
VRSK
20
Avantor Inc
AVTR
18
1
2
3
...
11
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Elanco Animal Health Inc's expected revenue for the next quarter?
Elanco Animal Health Inc's expected revenue is 1.31B.
What is Elanco Animal Health Inc's price target?
Analysts forecast that Elanco Animal Health Inc's price target is USD 25.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 18.00.
How have Elanco Animal Health IncELAN's recent earnings per share performed?
The market expectation was USD 0.11, while Elanco Animal Health IncELAN's earnings per share (EPS) for the previous quarter was USD -0.57. EPS for the next quarter is expected at USD 0.27.
What is the analyst rating for Elanco Animal Health Inc?
Based on the ratings of Elanco Animal Health Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.